
Mounjaro 15mg Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Mounjaro 15mg Injection
contains Tirzepatide 15mg per dose in a once-weekly KwikPen. This is the maximum approved dose of tirzepatide and delivers the highest achievable weight-loss and glycaemic efficacy in its class. In the landmark SURMOUNT-1 trial, 15mg tirzepatide achieved an average body weight reduction of 22.5% — the largest weight loss ever recorded in a Phase 3 obesity clinical trial for a weekly injectable medication.
Benefits:
- Maximum approved tirzepatide dose with unparalleled weight-loss efficacy
- Average 22.5% body weight reduction in SURMOUNT-1 (vs 15% for Wegovy)
- Normalises HbA1c in the majority of type 2 diabetes patients
- Dramatically reduces visceral fat, blood pressure, triglycerides, and LDL-C
- Reduces risk of type 2 diabetes development in high-risk individuals by over 90%
How It Works:
At 15mg, tirzepatide achieves maximal simultaneous activation of GIP and GLP-1 receptors. Hypothalamic appetite-suppressive signalling is at full capacity, producing profound satiety and substantially reduced food intake. Peripheral GIP receptor activation in adipocytes regulates fat storage and energy expenditure. Pancreatic beta-cell function is maximally supported, normalising glucose homeostasis in most patients. The sum of these effects delivers the most powerful metabolic transformation achievable with approved weekly injectable therapy.
Dosage and Administration:
Inject 15mg subcutaneously once weekly as the long-term maintenance dose, following completion of the escalation schedule (2.5→5→7.5→10→12.5→15mg). Administer into the abdomen, thigh, or outer upper arm at any time of day. Rotate injection sites each week. This is the maximum dose; do not exceed one 15mg pen per week.
Side Effects:
Common: nausea, diarrhoea, decreased appetite, vomiting, constipation, abdominal pain. Uncommon: fatigue, headache, increased resting heart rate, dyspepsia. Serious: acute pancreatitis, cholelithiasis, acute kidney injury, diabetic retinopathy complications.
Precautions:
Strictly contraindicated in personal or family history of medullary thyroid carcinoma or MEN2. Ensure adequate protein (≥1.2 g/kg ideal body weight) and micronutrient intake as food consumption is markedly reduced at this dose. Monitor for gallstone symptoms, mood changes, and dehydration.
Mounjaro Dosage Comparison Guide
| Strength | Best For | Onset | Duration | Link |
|---|---|---|---|---|
| 2.5mg | Lower strength option | 4–8 wks | Weekly | View → |
| 5mg | Standard strength option | 4–8 wks | Weekly | View → |
| 7.5mg | Popular strength option | 4–8 wks | Weekly | View → |
| 10mg | Popular strength option | 4–8 wks | Weekly | View → |
| 12.5mg | Higher strength option | 4–8 wks | Weekly | View → |
| 15mg | Maximum strength variant | 4–8 wks | Weekly | Current |
* Always consult your doctor before changing your dosage. This information is for educational reference only.
Frequently Asked Questions
Q1: What is Mounjaro 15mg used for?
Mounjaro 15mg is the maximum maintenance dose of tirzepatide, prescribed for long-term chronic weight management in adults with obesity or overweight with comorbidities, and for intensive glycaemic control in type 2 diabetes. It delivers the highest available weight-loss efficacy of any weekly injectable medication.
Q2: How much weight can I lose on Mounjaro 15mg?
In SURMOUNT-1, adults on tirzepatide 15mg with lifestyle changes lost an average of 22.5% of their starting body weight over 72 weeks. Approximately 1 in 3 participants lost over 25% of their body weight.
Q3: Is Mounjaro 15mg better than all other weight-loss injections?
In head-to-head trials (SURMOUNT-5), Mounjaro 10–15mg produced 47% more weight loss than Wegovy 2.4mg. As of 2025, tirzepatide 15mg delivers the largest average weight reduction of any approved weekly injectable for obesity.
Q4: Can Mounjaro 15mg reverse type 2 diabetes?
In the SURMOUNT-3 trial, 95% of participants at high risk of diabetes who took tirzepatide 15mg remained diabetes-free over 3 years, compared to 61% on placebo. While not a cure, tirzepatide 15mg can achieve sustained glycaemic normalisation in many patients.
Q5: How long does it take to reach 15mg?
The standard escalation from 2.5mg to 15mg takes 20 weeks (5 steps × 4 weeks each). Some prescribers use a slower 8-week per step schedule for patients with prominent side effects, taking 40 weeks to reach maintenance.
Q6: Will the weight-loss effect reduce over time on 15mg?
Weight loss typically plateaus after 52–72 weeks. However, weight is maintained as long as the medication continues. Stopping leads to gradual weight regain in most patients; long-term use is considered essential for sustained benefit.
Q7: Can Mounjaro 15mg cause heart problems?
Tirzepatide causes a modest increase in resting heart rate (2–4 bpm), which is generally clinically insignificant. No adverse cardiac outcomes have been demonstrated; cardiovascular outcome data from SURMOUNT-MMO show a reduction in MACE.
Q8: Do I need to change my diet significantly on Mounjaro 15mg?
Most patients on 15mg find their appetite severely reduced and naturally eat much less. However, the quality of food matters — focus on adequate protein, vegetables, and whole grains. Work with a dietitian to ensure nutritional needs are met despite reduced intake.
Q9: What happens to my metabolism when I stop Mounjaro 15mg?
Basal metabolic rate may decline proportionally with weight loss (metabolic adaptation). When Mounjaro is stopped, appetite returns and metabolic rate may not fully recover to pre-treatment levels, predisposing weight regain. Gradual discontinuation and continued lifestyle effort can mitigate this.
Q10: Can Mounjaro 15mg be used by patients over 65?
Older adults can use Mounjaro with appropriate monitoring. Age-related changes in renal function and risk of dehydration warrant careful attention. Start at the standard initiation dose and escalate cautiously. The benefits for cardiovascular and metabolic health are substantial in this population.
Customer Reviews
Global Meds Supply
Germany · 6 weeks ago
“Ordering from Medionix for several months now. Consistent pharmaceutical quality and professional service every time.”
Thomas B.
Australia · 4 months ago
“Legitimate pharmaceutical supplier. Packaging intact, expiry dates clearly printed, batch numbers traceable. Very satisfied.”
Robert Chen
Canada · 1 month ago
“Very satisfied with the order. Packaging was secure and delivery was on time. Quality matches the description perfectly.”
Dr. Emily Parker
UK · 2 months ago
“Impressed with the professionalism. Certificate of Analysis provided on request. Will be placing repeat orders for our clinic.”
Metro Hospital Pharmacy
UK · 2 weeks ago
“Reliable supplier. Product met all our quality standards. Great communication throughout the entire procurement process.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.





